AMKR vs LFUS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMKR demonstrates strong financial health with a Piotroski F-Score of 8/9, indicating robust operational efficiency and profitability trends. The company trades at a forward P/E of 18.15, below the sector average of 77.27, suggesting relative undervaluation despite high growth expectations. Earnings growth of 61% YoY and consistent earnings beats (3/4 in last 4 quarters) reinforce its momentum. However, the absence of an Altman Z-Score and bearish insider activity (4 sales totaling $2.83M) introduce cautionary signals. The intrinsic value of $44.25 exceeds the current price of $41.61, supporting a fair value upside.
LFUS presents a stable deterministic health profile with a Piotroski F-Score of 5/9 and exceptionally strong liquidity (Current Ratio 2.69). However, the stock is currently trading at its 52-week high following a massive 153% one-year rally, resulting in a stretched valuation with a PEG ratio of 2.46. While the company maintains a stellar 25-quarter earnings beat track record and healthy revenue growth, the current negative net profit margin and ROE are concerning. With a technical trend score of 10/100 and bearish insider activity, the stock appears to be in a consolidation or peak phase.
Compare Another Pair
Related Comparisons
AMKR vs LFUS: Head-to-Head Comparison
This page compares Amkor Technology, Inc. (AMKR) and Littelfuse, Inc. (LFUS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.